Who Paid My Doc
Rotateq
Biological Vaccine
NDC 0006-4047-41
General payments
$1,076,292
Research payments
$755,846
Through program year 2025, $1,076,292 in general payments and $755,846 in research payments were reported against Rotateq (Vaccine).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
11 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $207,533 | 10,269 |
| 2025 | Research | $67,272 | 4 |
| 2024 | General | $79,264 | 4,007 |
| 2024 | Research | $65,743 | 4 |
| 2023 | General | $177,813 | 9,561 |
| 2023 | Research | $57,819 | 4 |
| 2022 | General | $149,299 | 8,628 |
| 2021 | General | $153,454 | 9,679 |
| 2020 | General | $94,249 | 6,009 |
| 2019 | General | $214,681 | 13,255 |
| 2019 | Research | $565,012 | 7 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 96 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 52 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
61,408 general · 19 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.